In the interest of having accurate data points in this thread, and not posting random claims from twitter, could you please prove this claim about Deepak Fertilizer’s capacity expansion in Nitric acid?
As far as I’m aware from annual reports and investor presentations, there is no planned capex in nitric acid. They recently commissioned the plant at Dahej, and increase in volumes is from higher capacity utilization.
As you can see, a majority of DNA is consumed in house, and CNA volumes are similar to FY20.
Secondly, all communication hints at this quarter doing well because of TAN, not because of nitric acid.
-
Within the chemicals segment, TAN contributes 60% to the profits, Nitric acid contributes 20% to the profits (FY21).
-
Volumes in Q3FY22 were 6% higher in nitric acid, but TAN volumes were 24% higher (YoY).
-
The investor presentation says that the quarter has been a record quarter on TAN, and no comments on nitric acid.
